MGX
Metagenomi TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MGX vs peer average
41/100
MGX vs. peer average (F vs. D)
Grade spread
B 1 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
SCYX is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $50.65M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MGX
Metagenomi Therapeutics
SCYX
SCYNEXIS
Grade
F
F
Momentum
21
21
Value
57
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs SCYX
MGX / SCYX
Grade Position
Below peers
MGX vs. peer average (F vs. D)
41/100
Momentum
21
SCYXValue
57
MGXSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MGX
SCYX is the first peer returned for this comparison set.

